Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24th Annual Needham Healthcare Conference. Company management ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

Medical device, pharmaceutical, and life sciences expert tapped to lead Company’s technology strategy and global engineering ...

TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been named a winner of the 2025 BSMA ...

Design and communications studio Otherway has opened an office in New York and appointed Javier Passerieu to lead it as ...

Pragmatic NFC Connect product innovation expands market opportunities for edge and item-level intelligence at scale CAMBRIDGE, England, /CNW/ -- Pragmatic Semiconductor Ltd., a pioneer in flexible ...

We recently published a list of 10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher In this article, we are ...

Rebranding efforts include a new logo, overall brand presence, and corporate design.

Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim ...

Projected return on investment in pharma research and development (R&D) in 2024 has risen to 5.9%, continuing the upward ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24th Annual Needham Healthcare Conference. Company management will participate in a fireside chat on ...